StemoniX opens California site to focus on microOrgan research platform

By Maggie Lynch

- Last updated on GMT

(Image: Getty/Motorion)
(Image: Getty/Motorion)

Related tags California Technology Preclinical contract research preclinical development assays translational sciences Translational medicine models

StemoniX opens a new facility in California to house its research team working on its high-throughput microOrgan technology platforms for drug discovery and preclinical development.

MicroOrgans, the technology platform, uses assay plates that contain living microtissues engineered from human induced pluripotent stem cells (hiPSC). According to the company, it is the first ready-to-use platform of this type.

StemoniX also said that microOrgans are designed to enable high-throughput human drug screening without the need for drugs to enter a human body. The platform includes the microBrain and the microHeart to offer the potential to conduct research in these areas at a lower cost by not relying on animal models and human testing.

StemoniX also provides services to its partner organizations to screen compounds and create customized microORgan models and assays tailored to individual discovery and toxicity needs.

According to Ping Yeh, CEO of StemoniX, the company’s microOrgan platform has been used to develop a disease model for Rhett Syndrome as part of a research collaboration agreement with the National institute of Health’s (NIH) National Center for Advancing Translational sciences.

“Our new facility will enable us to build upon these and other innovations involving our microOrgans, while at the same time, fostering collaborations with forward-thinking pharmaceutical and biotech companies,”​ Yeh said in a statement.

Located in La Jolla, the new facility is near facilities for Janssen, Takeda, Vertex, and Celgene and other pharmaceutical companies, as well as biotech research labs.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars